journal article·2019-11-11

Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials

Sandra Hauser, Robert Wodtke, Christoph Tondera, Johanna Wodtke, Axel T. Neffe, Jochen Hampe, Andreas Lendlein, Reik Löser, Jens Pietzsch

Publisher page

Abstract

Tissue transglutaminase (TGase 2) is proposed to be important for biomaterial–tissue interactions due to its presence and versatile functions in the extracellular environment. TGase 2 catalyzes the cross-linking of proteins through its Ca2+-dependent acyltransferase activity. Moreover, it enhances the interactions between fibronectin and integrins, which in turn mediates the adhesion, migration, and motility of the cells. TGase 2 is also a key player in the pathogenesis of fibrosis. In this study, we investigated whether TGase 2 is present at the biomaterial–tissue interface and might serve as an informative biomarker for the visualization of tissue response toward gelatin-based biomaterials. Two differently cross-linked hydrogels were used, which were obtained by the reaction of gelatin with lysine diisocyanate ethyl ester. The overall expression of TGase 2 by endothelial cells, macrophages, and granulocytes was partly influenced by contact to the hydrogels or their degradation products, although no clear correlation was evidenced. In contrast, the secretion of TGase 2 differed remarkably between the different cells, indicating that it might be involved in the cellular reaction toward gelatin-based hydrogels. The hydrogels were implanted subcutaneously in immunocompetent, hairless SKH1-Elite mice. Ex vivo immunohistochemical analysis of tissue sections over 112 days revealed enhanced expression of TGase 2 around the hydrogels, in particular at days 14 and 21 post-implantation. The incorporation of fluorescently labeled cadaverine derivatives for the detection of active TGase 2 was in accordance with the results of the expression analysis. The presence of an irreversible inhibitor of TGase 2 led to attenuated incorporation of the cadaverines, which verified the catalytic action of TGase 2. Our in vitro and ex vivo results verified TGase 2 as a potential biomarker for tissue response toward gelatin-based hydrogels. In vivo, no TGase 2 activity was detectable, which is mainly attributed to the unfavorable physicochemical properties of the cadaverine probe used.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Blood properties and coagulation · Tendon Structure and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden 01328, Germany

Biotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden 01307, Germany

Helmholtz Virtual Institute on Multifunctional Biomaterials for Medicine, Teltow 14513, Germany

Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Teltow 14513, Germany

Medical Department 1, University Hospital Dresden, Technische Universität Dresden, Dresden 01307, Germany

Institute of Chemistry, University of Potsdam, Potsdam 14469, Germany

Faculty of Chemistry and Food Chemistry, School of Sciences, Technische Universität Dresden, Dresden 01307, Germany

Funding

Helmholtz-Gemeinschaft · Deutsche Forschungsgemeinschaft

References (42)

Show source-provided references
1. 10.1016/j.bmcl.2013.09.06010.1016/j.bmcl.2013.09.060 ↗
2. 10.1007/s00726-011-1008-x10.1007/s00726-011-1008-x ↗
3. 10.1111/j.1742-4658.2011.08346.x10.1111/j.1742-4658.2011.08346.x ↗
4. 10.1016/S0968-0004(02)02182-510.1016/S0968-0004(02)02182-5 ↗
5. 10.1074/jbc.M80176320010.1074/jbc.M801763200 ↗
6. 10.1371/journal.pbio.005032710.1371/journal.pbio.0050327 ↗
7. 10.1073/pnas.04245489910.1073/pnas.042454899 ↗
8. 10.1007/s00726-010-0500-z10.1007/s00726-010-0500-z ↗
9. 10.1007/BF0022908410.1007/BF00229084 ↗
10. 10.2741/184310.2741/1843 ↗
11. 10.1182/blood.V98.5.156710.1182/blood.V98.5.1567 ↗
12. 10.1111/j.1600-0609.1991.tb01537.x10.1111/j.1600-0609.1991.tb01537.x ↗
13. 10.1007/s00726-004-0094-410.1007/s00726-004-0094-4 ↗
14. 10.1038/cddis.2013.31810.1038/cddis.2013.318 ↗
15. Mearns B. · Minerva Biotechnologica · 2002 · 14 · 218
16. 10.1002/mabi.20110023710.1002/mabi.201100237 ↗
17. 10.1016/j.biomaterials.2014.08.02310.1016/j.biomaterials.2014.08.023 ↗
18. 10.7150/thno.1661410.7150/thno.16614 ↗
19. 10.1007/s00726-016-2192-510.1007/s00726-016-2192-5 ↗
20. 10.1021/acs.jmedchem.8b0028610.1021/acs.jmedchem.8b00286 ↗
21. 10.1021/ml300241m10.1021/ml300241m ↗
22. 10.1007/s00726-010-0822-x10.1007/s00726-010-0822-x ↗
23. 10.4049/jimmunol.080344410.4049/jimmunol.0803444 ↗
24. 10.3390/ma809526910.3390/ma8095269 ↗
25. 10.1371/journal.pone.001941410.1371/journal.pone.0019414 ↗
26. 10.1038/3507000910.1038/35070009 ↗
27. 10.1096/fasebj.13.13.178710.1096/fasebj.13.13.1787 ↗
28. 10.4062/biomolther.2012.20.4.38010.4062/biomolther.2012.20.4.380 ↗
29. 10.1152/physrev.00019.201310.1152/physrev.00019.2013 ↗
30. 10.1016/S0002-9440(10)64826-210.1016/S0002-9440(10)64826-2 ↗
31. 10.1016/S1357-2725(01)00033-410.1016/S1357-2725(01)00033-4 ↗
32. 10.1016/S0923-1811(03)00091-410.1016/S0923-1811(03)00091-4 ↗
33. 10.3892/ijmm_0000003610.3892/ijmm_00000036 ↗
34. 10.1023/A:102648422785110.1023/A:1026484227851 ↗
35. 10.1016/S0014-5793(02)03836-X10.1016/S0014-5793(02)03836-X ↗
36. 10.1016/j.nucmedbio.2016.01.00310.1016/j.nucmedbio.2016.01.003 ↗
37. 10.1016/j.nucmedbio.2016.10.00210.1016/j.nucmedbio.2016.10.002 ↗
38. 10.1371/journal.pone.000186110.1371/journal.pone.0001861 ↗
39. 10.1074/jbc.M109.09716210.1074/jbc.M109.097162 ↗
40. 10.1021/bi002321t10.1021/bi002321t ↗
41. 10.1074/jbc.M111.28749010.1074/jbc.M111.287490 ↗
42. 10.4081/ijas.2008.13110.4081/ijas.2008.131 ↗